These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28324909)

  • 21. The internal jugular vein as an alternative venous access for a revision of a fractured implantable cardioverter-defibrillator lead.
    Pae JY; Kim YN; Do MY; Park HS; Han S; Hur SH; Choi SY
    Korean J Intern Med; 2017 Mar; 32(2):360-362. PubMed ID: 26842100
    [No Abstract]   [Full Text] [Related]  

  • 22. A randomized study of defibrillator lead implantations in the right ventricular mid-septum versus the apex: the SEPTAL study.
    Mabo P; Defaye P; Mouton E; Cebron JP; Davy JM; Tassin A; Babuty D; Mondoly P; Paziaud O; Anselme F; Daubert JC
    J Cardiovasc Electrophysiol; 2012 Aug; 23(8):853-60. PubMed ID: 22452288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable cardioverter defibrillator therapy in young individuals: comparison of conventional and subcostal approaches-a single-centre experience.
    Irfan G; Czapla J; Saitoh Y; Ciconte G; Mugnai G; Conte G; Hunuk B; Velagic V; Stroker E; Chierchia GB; Nijs J; La Meir M; Wellens F; Brugada P; De Asmundis C
    Europace; 2017 Jan; 19(1):81-87. PubMed ID: 26893495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When to consider an implantable cardioverter defibrillator following myocardial infarction?
    Szwejkowski BR; Wright GA; Connelly DT; Gardner RS
    Heart; 2015 Dec; 101(24):1996-2000. PubMed ID: 26526420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is defibrillation testing necessary?
    Russo AM; Chung MK
    Cardiol Clin; 2014 May; 32(2):211-24. PubMed ID: 24793798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.
    Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S;
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantation of additional defibrillation lead into the coronary sinus: an effective method of decreasing defibrillation threshold.
    Wilczek R; Swiątkowski M; Czepiel A; Sterliński M; Makowska E; Kułakowski P
    Kardiol Pol; 2011; 69(12):1308-9. PubMed ID: 22219117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous implantable cardioverter defibrillator in a patient with pectus excavatum.
    Hamoud A; Barry J
    Pacing Clin Electrophysiol; 2013 May; 36(5):e138-9. PubMed ID: 22554273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early-Morning Type Ventricular Fibrillation With J Wave.
    Fujino T; Yamazaki Y; Tsubota T; Ikeda T
    Int Heart J; 2015; 56(4):459-61. PubMed ID: 26084458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?
    Randles DA; Hawkins NM; Shaw M; Patwala AY; Pettit SJ; Wright DJ
    Europace; 2014 Jul; 16(7):1015-21. PubMed ID: 24351884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inappropriate shock from a subcutaneous implantable cardioverter-defibrillator due to transcutaneous electrical nerve stimulation.
    Miller MA; Palaniswamy C; Sharma D; Reddy VY
    Heart Rhythm; 2015 Jul; 12(7):1702-3. PubMed ID: 25889810
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
    Healey JS; Hohnloser SH; Glikson M; Neuzner J; Mabo P; Vinolas X; Kautzner J; O'Hara G; VanErven L; Gadler F; Pogue J; Appl U; Gilkerson J; Pochet T; Stein KM; Merkely B; Chrolavicius S; Meeks B; Foldesi C; Thibault B; Connolly SJ;
    Lancet; 2015 Feb; 385(9970):785-91. PubMed ID: 25715991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of ventricular fibrillation in relation to cardiac aetiology and shock success: A waveform analysis study in ICD-patients.
    Bonnes JL; Keuper W; Westra SW; Zegers ES; Oostendorp TF; Brouwer MA; Smeets JL
    Resuscitation; 2015 Jan; 86():95-9. PubMed ID: 25449343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing should not be routinely performed at the time of implantable cardioverter defibrillator implantation.
    Healey JS; Brambatti M
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):347-51. PubMed ID: 24736424
    [No Abstract]   [Full Text] [Related]  

  • 35. The Potential Impact of Intrathoracic Impedance on Defibrillation Threshold Testing in S-ICDs.
    Cheung CC; Larsen JM; Bashir J; Dorian P; Laksman ZW
    Can J Cardiol; 2019 Nov; 35(11):1604.e13-1604.e16. PubMed ID: 31587933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous implantable cardioverter-defibrillator (S-ICD).
    Lobodzinski SS
    Cardiol J; 2011; 18(3):326-31. PubMed ID: 21660928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 38. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 39. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation.
    Russo AM; Chung MK
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):337-46. PubMed ID: 24736423
    [No Abstract]   [Full Text] [Related]  

  • 40. Device therapy: High-zone programming of ICDs reduces inappropriate shocks.
    Huynh K
    Nat Rev Cardiol; 2015 Apr; 12(4):193. PubMed ID: 25732361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.